This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Injury of nerves at ankle and foot level
ST19_INJURY_NERVES_ANKLE_FOOT_LEVEL
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
272 |
4. Check minimum number of eventsNone |
272 |
5. Include endpointsNone |
272 |
6. Filter based on genotype QC (FinnGen only) |
258 |
Control definitions (FinnGen only)
- Control exclude
- ST19_INJURI_ANKLE_FOOT
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- S90
- Name in latin
- Laesio nervorum regionis tarsi/pedis
Similar endpoints
↥List of similar endpoints to
Injury of nerves at ankle and foot level
based on the number of shared cases.
Similar with more cases:
- Injuries to the ankle and foot
- Injury, poisoning and certain other consequences of external causes
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 258 | 144 | 114 |
| Unadjusted period prevalence (%) | 0.05 | 0.05 | 0.05 |
| Median age at first event (years) | 45.64 | 42.28 | 49.87 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 272
- Matched controls
- 2720
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
S94.3
ICD-10 Finland
Injury of cutaneous sensory nerve at ankle and foot level
+∞
113.7
101
*
S94.2
ICD-10 Finland
Injury of deep peroneal nerve at ankle and foot level
+∞
51.7
48
*
S94.8
ICD-10 Finland
Injury of other nerves at ankle and foot level
+∞
50.6
47
*
S93.4
ICD-10 Finland
Sprain and strain of ankle
9.4
49.5
68
93
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
9.9
41.7
53
65
S94.9
ICD-10 Finland
Injury of unspecified nerve at ankle and foot level
+∞
39.5
37
*
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
4.9
36.9
127
412
X58
ICD-10 Finland
Exposure to other specified factors
5.6
35.9
86
206
NHU20
NOMESCO Finland
Removal of internal fixation device from ankle or foot
11.7
33.2
36
35
X59
ICD-10 Finland
Exposure to unspecified factor
4.9
32.6
98
282
N03AX12
ATC
[U] gabapentin; oral
4.3
25.1
85
262
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
6.1
23.2
44
83
N03AX16
ATC
[U] pregabalin
3.7
23.1
102
376
W19
ICD-10 Finland
Unspecified fall
5.6
22.8
48
100
NHL30
NOMESCO Finland
Suture or reinsertion of tendon of foot
59.5
19.2
22
*
S94.7
ICD-10 Finland
Injury of multiple nerves at ankle and foot level
+∞
19.0
18
*
S94.0
ICD-10 Finland
Injury of lateral plantar nerve
+∞
17.9
17
*
N06AX21
ATC
duloxetine; oral
4.0
17.6
59
177
TNX33
NOMESCO Finland
Custom moulded cast, unspecified region
7.0
17.0
27
42
W22
ICD-10 Finland
Striking against or struck by other object(s)
5.2
16.9
38
83
TQW40
NOMESCO Finland
Remowal of suture of skin
5.3
16.9
37
79
NHJ10
NOMESCO Finland
Internal fixation of fracture of ankle using wire, rod, cerclage or pin
6.4
16.6
29
50
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
4.0
16.3
53
155
M79.6
ICD-10 Finland
Pain in limb
2.8
15.1
147
814
S82.6
ICD-10 Finland
Fracture of lateral malleolus
5.3
14.7
31
64
N02AX02
ATC
tramadol; systemic, rectal
2.7
14.4
136
737
M25.5
ICD-10 Finland
Pain in joint
2.7
14.3
115
574
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
6.2
13.9
25
44
ZXE10
NOMESCO Finland
More than one and less than three hours
2.7
13.9
117
597
NHF25
NOMESCO Finland
Operation for debridement of ankle joint, arthroscopic
79.2
13.7
15
*
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
2.6
13.1
146
846
L16
ICPC
Ankle symptom/complaint
3.6
13.0
49
158
M19.0
ICD-10 Finland
Primary arthrosis of other joints
3.8
12.8
43
128
NH1AD
NOMESCO Finland
Ankle and foot CT
18.4
12.7
19
11
S94.1
ICD-10 Finland
Injury of medial plantar nerve
+∞
12.6
12
*
S91.3
ICD-10 Finland
Open wound of other parts of foot
19.2
12.2
18
10
M89.0
ICD-10 Finland
Algoneurodystrophy
28.2
12.2
16
6
NG4AA
NOMESCO Finland
Lower leg X-ray examination
6.2
12.0
21
36
TNX50
NOMESCO Finland
Removal of cutom molded cast and internal stretch
5.9
11.8
22
40
NH1CG
NOMESCO Finland
Ankle and foot extensive MRI examination with high intensity magnet
17.4
11.8
18
11
Z3226
NOMESCO Finland
Physiotherapist
2.9
11.3
65
269
TNX32
NOMESCO Finland
Custom moulded splint, unspecified region
5.5
11.0
22
43
N02AJ06
ATC
codeine and paracetamol; systemic
2.4
10.9
140
845
B01AB05
ATC
enoxaparin; parenteral
2.5
10.9
95
483
R4120
NOMESCO Finland
Occupational therapy
4.3
10.8
29
73
WX320
NOMESCO Finland
Spinalanesthesy
2.6
10.5
80
380
XA402
NOMESCO Finland
ENMG
10.2
10.4
20
21
T93.2
ICD-10 Finland
Sequelae of other fractures of lower limb
24.5
10.3
14
6
A02BC02
ATC
pantoprazole; systemic
2.4
10.3
192
1346
G57.3
ICD-10 Finland
Lesion of lateral popliteal nerve
13.9
10.3
17
13
NH1BG
NOMESCO Finland
Ankle and foot MRI examination with high intensity magnet
12.0
9.7
17
15
R4110
NOMESCO Finland
Physiotherapy
2.4
9.4
89
464
N06AA09
ATC
amitriptyline; systemic
3.5
9.4
34
106
N03AX09
ATC
lamotrigine; oral
4.1
9.0
26
69
Z09.4
ICD-10 Finland
Follow-up examination after treatment of fracture
4.5
8.8
22
52
S18
ICPC
Laceration/cut
2.2
8.7
132
829
R52.2
ICD-10 Finland
Other chronic pain
4.7
8.5
20
45
M23.9
ICD-10 Finland
Internal derangement of knee, unspecified
3.2
8.5
36
124
M54.5
ICD-10 Finland
Low back pain
2.2
8.5
111
658
S96.1
ICD-10 Finland
Injury of muscle and tendon of long extensor muscle of toe at ankle and foot level
+∞
8.4
8
*
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.8
8.4
26
73
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.3
8.3
82
432
H02AB06
ATC
prednisolone; systemic
2.1
8.3
130
823
L17
ICPC
Foot/toe symptom/complaint
2.3
8.3
86
463
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
5.0
8.2
18
38
S92.3
ICD-10 Finland
Fracture of metatarsal bone
12.2
8.2
14
12
N03AE01
ATC
clonazepam; systemic
4.1
8.2
23
60
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
3.2
8.1
34
116
TNX92
NOMESCO Finland
Supporting bandage or orthosis of lower limb
10.5
8.1
15
15
M19.1
ICD-10 Finland
Post-traumatic arthrosis of other joints
7.6
8.1
18
25
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
3.6
8.0
27
80
S82.8
ICD-10 Finland
Fractures of other parts of lower leg
4.9
8.0
18
39
S93.2
ICD-10 Finland
Rupture of ligaments at ankle and foot level
15.6
7.8
12
8
NHE15
NOMESCO Finland
Suture or reinsertion of ligament of ankle
46.3
7.8
9
*
ZXA00
NOMESCO Finland
Right side
2.3
7.6
74
386
T88.8
ICD-10 Finland
Other specified complications of surgical and medical care, not elsewhere classified
25.8
7.6
10
*
ZZH21
NOMESCO Finland
Graft of patients own bone, small pieces
10.5
7.6
14
14
M03BX02
ATC
tizanidine; oral
2.1
7.6
183
1342
M03BC01
ATC
orphenadrine (citrate); systemic
2.2
7.6
79
424
ZXD10
NOMESCO Finland
Scheduled procedure
2.1
7.6
106
639
ACC59
NOMESCO Finland
Decompression and freeing of adhesions of peripheral nerve: other or unspecified
4.6
7.5
18
41
N02BE01
ATC
paracetamol; systemic, rectal
3.3
7.5
249
2088
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.8
7.5
40
157
M75.1
ICD-10 Finland
Rotator cuff syndrome
2.2
7.5
75
396
SPAT1215
SPAT
Assessment of need for medical rehabilitation
4.5
7.3
18
42
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.9
7.3
37
141
ABD32
NOMESCO Finland
Implantation of temporary spinal stimulation device
16.3
7.3
11
7
ACC29
NOMESCO Finland
Reconstruction of peripheral nerve: other or unspecified
20.7
7.2
10
5
G57.8
ICD-10 Finland
Other mononeuropathies of lower limb
20.7
7.2
10
5
L28
ICPC
Limited function/disability (L)
2.6
7.2
47
205
M79.2
ICD-10 Finland
Neuralgia and neuritis, unspecified
10.4
7.1
13
13
S06.0
ICD-10 Finland
Concussion
2.7
7.1
40
162
M76.8
ICD-10 Finland
Other enthesopathies of lower limb, excluding foot
7.9
7.0
15
20
NH1BA
NOMESCO Finland
Ankle extensive X-ray examination
8.6
6.9
14
17
ZXA05
NOMESCO Finland
Left side
2.2
6.9
66
342
ABD30
NOMESCO Finland
Implantation of spinal stimulation device
17.2
6.8
10
6
Z3231
NOMESCO Finland
Registered nurse
2.1
6.8
81
457
R03AC02
ATC
salbutamol; inhalant
2.0
6.7
158
1128
WX213
NOMESCO Finland
Lower leg blockade
23.2
6.7
9
*
N05AH04
ATC
quetiapine; oral
2.2
6.6
61
310
N05CF01
ATC
zopiclone; oral
2.0
6.5
85
495
T93.4
ICD-10 Finland
Sequelae of injury of nerve of lower limb
71.5
6.5
7
*
T36
ICD-10 Finland
Poisoning by systemic antibiotics
3.8
6.4
20
56
N06AX16
ATC
venlafaxine; oral
2.4
6.4
49
230
S94
ICD-10 Finland
Injury of nerves at ankle and foot level
+∞
6.3
6
*
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
4.2
6.3
17
43
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.2
6.2
59
304
R52.9
ICD-10 Finland
Pain, unspecified
2.7
6.1
34
136
NGA30
NOMESCO Finland
Exploration of knee joint, arthroscopic
3.6
6.1
20
58
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
3.5
6.1
21
63
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.1
6.1
64
342
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
133
877
2.01
7.35
8.9
9.9
1.05
1.18
inr
3.37
33
272
79
467
1.97
5.70
2.0
1.7
0.85
1.09
mg/l
0.60
56
359
165
1255
1.80
5.19
9.1
9.1
4.23
4.05
e9/l
0.41
142
1085
147
1084
1.77
5.11
6.7
6.1
11.17
10.90
umol/l
0.15
141
1026
197
1591
1.86
4.97
4.8
3.6
10.06
9.47
mm/h
0.30
181
1475
25
96
2.77
4.88
1.8
1.6
—
—
—
0
0
107
739
1.74
4.53
2.2
1.8
99.13
95.56
pmol/l
0.32
63
382
52
287
2.00
4.48
2.2
1.8
—
—
—
0
0
114
807
1.71
4.39
4.5
4.5
35.07
36.54
g/l
1.80
105
763
57
337
1.87
4.00
3.2
3.4
967.92
161.00
ng/l
0.57
37
232
77
503
1.74
3.88
3.1
2.1
—
—
—
0
0
133
1019
1.60
3.55
2.9
2.5
—
—
—
0
0
71
472
1.68
3.31
2.4
2.0
3.20
3.01
mg/l
0.21
57
404
19
78
2.54
3.29
2.9
2.2
—
—
—
0
0
152
1215
1.57
3.29
5.6
4.3
6.36
6.56
mmol/l
0.67
145
1114
193
1633
1.63
3.26
8.8
7.1
75.82
74.34
u/l
0.23
185
1535
119
910
1.55
3.08
6.3
6.1
1.22
1.21
mmol/l
0.23
109
774
112
849
1.54
2.99
6.6
5.2
1.22
1.21
mmol/l
0.35
104
771
111
845
1.53
2.89
2.4
2.2
72.05
75.16
nmol/l
0.67
99
760
6
9
6.79
2.88
4.3
1.6
—
—
—
0
0
20
90
2.32
2.88
2.0
1.8
—
—
—
0
0
11
33
3.43
2.84
1.7
1.2
—
—
—
0
0
82
586
1.57
2.82
2.4
2.0
977.32
350.17
u/l
0.44
77
555
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
12
39
3.17
2.81
2.6
2.1
0.25
0.33
u/ml
—
7
23
100
748
1.53
2.81
3.4
3.2
16.20
34.93
ng/l
2.30
59
460
234
2116
1.76
2.68
14.5
10.6
88.02
87.63
ml/min/173m2
0.10
200
1709
78
558
1.56
2.65
3.4
2.7
0.22
0.28
e6/l
0.25
62
420
244
2238
1.88
2.60
17.2
12.7
3.96
3.95
mmol/l
0.16
239
2173
243
2228
1.85
2.56
17.6
12.7
139.49
139.69
mmol/l
0.60
238
2168
99
752
1.50
2.54
3.0
3.0
33.15
30.72
u/l
0.27
94
715
17
76
2.32
2.50
2.9
2.0
—
—
—
0
0
62
429
1.58
2.42
1.6
1.4
18.82
20.51
nmol/l
0.45
51
366
47
306
1.65
2.35
2.7
2.5
2.53
2.78
e6/l
0.07
23
159
32
190
1.78
2.22
1.9
1.6
—
—
—
0
0
243
2247
1.76
2.22
18.0
11.8
19.46
21.54
mg/l
0.55
205
1723
27
152
1.86
2.21
2.7
3.4
3.47
2.07
mmol/l
0.79
19
117
54
371
1.57
2.17
1.4
1.3
12.45
27.80
iu/ml
2.23
20
126
6
14
4.36
2.16
5.3
2.6
39516.67
32914.64
ug/l
—
6
14
7
20
3.56
2.07
1.4
2.0
—
—
—
0
0
7
20
3.56
2.07
1.4
2.0
—
—
—
0
0
7
20
3.56
2.07
1.4
2.0
—
—
—
0
0
12
50
2.46
2.05
1.0
1.9
—
—
—
0
0
9
32
2.87
2.02
1.8
1.8
—
—
—
0
0
9
32
2.87
2.02
1.8
1.8
—
—
—
0
0
188
1662
1.42
1.94
3.8
3.9
14.58
14.66
pmol/l
0.16
171
1517
31
191
1.70
1.91
2.0
1.7
—
—
—
0
0
47
323
1.55
1.89
2.7
2.4
1.20
0.72
e6/l
0.24
23
175
189
1678
1.41
1.86
3.4
3.5
—
—
—
0
0
5
12
4.22
1.83
1.0
1.3
—
—
—
0
0
50
351
1.52
1.83
2.1
1.7
1.61
1.43
%
0.86
44
312
17
88
1.99
1.79
1.9
3.0
223.92
185.85
ng/l
0.08
12
78
253
2394
1.81
1.74
11.9
9.2
28.45
26.62
u/l
0.87
247
2326
5
13
3.90
1.72
1.0
1.1
186.80
128.45
iu/ml
—
5
13
90
716
1.38
1.70
3.6
2.9
—
—
—
0
0
45
314
1.52
1.69
1.9
1.6
985.04
1199.70
nmol/l
0.95
31
249
6
19
3.20
1.67
1.0
1.1
—
—
—
0
0
7
26
2.74
1.59
1.0
1.2
—
—
—
0
0
7
26
2.74
1.59
1.0
1.2
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
15
3.37
1.53
1.0
1.3
—
—
—
0
0
25
156
1.66
1.50
1.2
1.2
—
23.96
—
0
9
21
125
1.74
1.48
2.3
1.5
—
—
—
0
0
11
53
2.12
1.40
3.3
2.5
—
—
—
0
0
49
362
1.43
1.40
1.3
1.3
1.16
8.37
u/ml
2.72
17
151
6
23
2.64
1.37
1.3
2.0
—
—
—
0
0
23
144
1.65
1.37
2.3
2.1
15.15
8.42
ug/l
0.34
15
130
79
638
1.34
1.33
2.4
3.4
2.35
2.35
mmol/l
0.05
67
571
217
2020
1.37
1.26
5.0
4.5
1.71
2.40
mu/l
0.62
202
1866
81
662
1.32
1.25
3.4
2.5
71.47
55.10
u/l
0.51
76
622
5
19
2.66
1.22
2.4
1.7
—
—
—
0
0
5
19
2.66
1.22
2.4
1.7
—
—
—
0
0
12
64
1.92
1.20
1.3
1.3
—
8.60
—
0
12
6
26
2.34
1.19
1.3
2.0
—
—
—
0
0
35
252
1.45
1.16
5.1
3.8
29.32
31.73
%
0.64
22
175
5
21
2.41
1.09
1.2
1.0
—
—
—
0
0
63
506
1.32
1.09
1.8
1.5
—
—
—
0
0
7
32
2.22
1.09
1.9
1.3
—
—
—
0
0
7
32
2.22
1.09
1.9
1.3
—
—
—
0
0
122
1068
1.26
1.08
3.5
3.3
0.00
0.00
estimate
0.50
26
231
43
331
1.36
0.99
2.1
2.8
2.45
2.43
mmol/l
0.45
38
292
5
23
2.20
0.98
1.4
1.1
0.62
1.29
promille
—
5
18
59
478
1.30
0.96
3.0
2.9
950.37
1132.94
ng/l
0.27
48
394
6
27
2.25
0.94
1.2
1.3
—
—
—
0
0
9
52
1.76
0.93
1.8
1.6
—
—
—
0
0
6
29
2.09
0.90
1.3
1.4
—
—
—
0
0
176
1629
1.23
0.86
3.8
2.9
56.96
43.39
u/l
0.87
169
1539
208
1960
1.26
0.86
5.8
4.9
38.42
39.10
mmol/mol
0.43
194
1852
27
198
1.40
0.84
3.0
3.2
—
—
—
0
0
30
227
1.36
0.79
8.6
6.6
105.27
104.04
mmol/l
0.77
30
227
261
2548
1.60
0.76
25.1
17.2
4.49
4.56
e12/l
1.40
254
2481
11
67
1.67
0.76
1.4
1.5
—
256.00
—
0
5
12
75
1.63
0.76
1.6
1.1
—
—
—
0
0
9
54
1.69
0.75
1.9
1.1
—
—
—
0
0
118
1062
1.20
0.74
5.0
4.6
0.00
0.00
estimate
-0.00
26
220
7
39
1.82
0.73
2.1
3.6
56.00
57.31
%
—
7
39
7
39
1.82
0.73
1.1
1.2
—
—
—
0
0
12
76
1.61
0.73
1.6
1.1
—
—
—
0
0
9
57
1.60
0.72
1.3
1.3
—
46.58
—
0
6
228
2186
1.27
0.71
4.1
4.0
4.78
4.70
mmol/l
0.58
211
2065
119
1075
1.19
0.71
3.6
3.4
0.00
0.00
estimate
-0.00
24
208
61
517
1.23
0.70
2.7
2.5
12405.12
6910.98
umol/l
0.18
50
457
30
380
0.76
0.68
1.3
1.4
—
—
—
0
0
110
991
1.18
0.67
3.2
2.7
98.80
100.37
ug/l
0.05
103
926
11
70
1.60
0.66
1.7
1.4
256.83
298.39
ug/g
—
6
39
260
2545
1.49
0.63
25.2
17.2
259.44
251.11
e9/l
1.26
254
2486
9
138
0.64
0.62
7.7
3.6
1.19
1.22
mmol/l
—
9
120
15
105
1.45
0.61
1.3
1.3
242.26
296.58
miu/ml
—
9
52
260
2546
1.48
0.61
24.9
17.2
40.28
40.74
%
0.67
253
2424
0
20
0.00
0.60
0.0
1.3
—
—
—
0
0
0
23
0.00
0.58
0.0
3.5
—
86.16
—
0
23
6
40
1.51
0.52
1.0
1.2
—
—
—
0
0
25
198
1.29
0.51
9.2
7.4
2.75
0.97
mmol/l
0.90
19
156
61
534
1.18
0.51
1.4
1.2
0.82
1.39
u/ml
0.87
19
159
16
119
1.37
0.49
1.3
1.3
—
—
—
0
0
50
575
0.84
0.49
4.1
3.6
0.00
0.00
estimate
-0.00
26
217
225
2177
1.19
0.49
4.2
3.9
1.38
1.45
mmol/l
2.04
208
2045
5
84
0.59
0.46
1.6
1.6
—
—
—
0
0
7
50
1.41
0.45
2.0
1.6
—
—
—
0
0
7
50
1.41
0.45
2.1
1.5
—
—
—
0
0
65
579
1.16
0.45
1.7
1.6
1.61
1.43
mmol/l
0.61
58
500
11
78
1.43
0.44
1.3
1.2
—
—
—
0
0
21
261
0.79
0.43
1.7
1.7
—
—
—
0
0
5
31
1.62
0.43
1.6
1.6
—
—
—
0
0
5
31
1.62
0.43
1.6
1.6
—
—
—
0
0
5
31
1.62
0.43
1.6
1.6
—
—
—
0
0
5
31
1.62
0.43
1.6
1.6
—
—
—
0
0
5
32
1.57
0.42
1.6
1.6
—
—
—
0
0
5
32
1.57
0.42
1.6
1.6
—
—
—
0
0
5
32
1.57
0.42
1.6
1.6
—
—
—
0
0
5
33
1.52
0.41
2.0
1.6
—
—
—
0
0
0
16
0.00
0.41
0.0
1.1
—
1.10
—
0
5
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
0
17
0.00
0.41
0.0
1.7
—
—
—
0
0
8
60
1.34
0.40
1.5
1.2
—
—
—
0
0
11
80
1.39
0.39
1.5
1.6
—
—
—
0
0
6
41
1.47
0.36
1.8
1.6
—
—
—
0
0
16
199
0.79
0.34
1.4
1.6
—
—
—
0
0
18
147
1.24
0.31
1.9
1.3
—
—
—
0
0
7
53
1.33
0.31
1.0
1.3
—
—
—
0
0
7
53
1.33
0.31
1.4
1.3
—
—
—
0
0
227
2221
1.13
0.29
4.5
4.3
2.82
2.81
mmol/l
0.06
210
2085
216
2109
1.12
0.28
4.6
3.9
5.81
5.82
mmol/l
0.02
199
1953
8
66
1.22
0.27
2.9
1.9
160.63
230.28
pmol/l
—
8
61
215
2102
1.11
0.25
3.8
3.5
1.44
1.29
mmol/l
1.62
199
1959
19
161
1.19
0.25
2.6
2.7
79.20
71.42
ml/min/173m2
—
10
72
5
38
1.32
0.23
2.2
1.6
—
—
—
0
0
34
376
0.89
0.22
3.5
2.7
0.67
0.68
ug/l
0.02
21
232
5
42
1.19
0.21
1.2
1.1
—
—
—
0
0
8
103
0.77
0.21
1.8
1.9
—
—
—
0
0
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
0
10
0.00
0.21
0.0
2.4
—
—
—
0
0
0
10
0.00
0.21
0.0
2.4
—
—
—
0
0
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
5
43
1.17
0.21
1.2
1.2
—
—
—
0
0
0
13
0.00
0.21
0.0
1.6
—
1.50
—
0
8
49
529
0.91
0.20
4.8
3.7
4.68
9.06
mg/mmol
1.13
33
337
0
14
0.00
0.20
0.0
1.1
—
37.29
—
0
14
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
112.26
—
0
14
0
14
0.00
0.20
0.0
1.9
—
—
—
0
0
6
51
1.18
0.19
1.3
1.3
—
—
—
0
0
47
505
0.92
0.18
4.0
4.0
19.52
20.62
%
0.16
18
227
7
59
1.19
0.18
1.6
1.1
—
—
—
0
0
48
447
1.09
0.17
2.1
2.2
—
—
—
0
0
10
82
1.23
0.17
1.6
1.6
—
—
—
0
0
7
63
1.11
0.17
1.1
2.0
—
—
—
0
0
68
644
1.07
0.17
5.0
4.4
6.18
2.02
ug/l
0.52
62
575
5
69
0.72
0.17
1.6
1.5
—
—
—
0
0
8
72
1.11
0.16
1.0
1.8
—
—
—
0
0
8
97
0.82
0.14
1.5
1.4
—
—
—
0
0
26
238
1.10
0.13
2.1
1.9
—
—
—
0
0
5
45
1.11
0.10
6.0
2.4
254.00
73.60
ug/min
—
5
30
5
47
1.07
0.09
1.6
1.3
194.34
232.55
u/ml
—
5
29
5
48
1.04
0.09
1.2
2.2
0.00
0.00
g/l
—
5
48
5
48
1.04
0.09
1.2
2.2
0.00
0.00
g/l
—
5
48
18
168
1.08
0.06
12.1
8.1
126.72
122.54
g/l
0.29
18
162
86
843
1.03
0.05
3.6
3.4
—
—
—
0
0
10
110
0.91
0.05
1.3
1.4
—
—
—
0
0
10
110
0.91
0.05
1.3
1.4
—
—
—
0
0
13
140
0.92
0.04
1.1
1.0
—
—
—
0
0
42
408
1.03
0.04
1.9
2.0
—
—
—
0
0
10
109
0.91
0.04
1.3
1.4
—
—
—
0
0
10
109
0.91
0.04
1.3
1.4
—
—
—
0
0
19
196
0.97
0.00
1.8
1.8
—
—
—
0
0
11
108
1.02
0.00
28.4
7.8
27.46
24.60
mmol/l
0.85
11
101
13
129
1.01
0.00
1.5
1.5
—
—
—
0
0
24
241
1.00
0.00
9.5
6.2
—
—
—
0
0
11
107
1.03
0.00
4.6
5.1
24.10
24.59
mmol/l
0.16
11
107
12
125
0.96
0.00
1.3
1.6
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
0
6
0.00
0.00
0.0
2.5
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.7
—
—
—
0
0
0
8
0.00
-0.00
0.0
3.3
—
—
—
0
0
0
8
0.00
-0.00
0.0
3.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.3
—
6.49
—
0
9
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
23.56
—
0
7
5
52
0.96
-0.00
1.2
2.1
0.00
0.00
g/l
—
5
52
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: ST19_INJURY_NERVES_ANKLE_FOOT_LEVEL – Injury of nerves at ankle and foot level
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).